- Exchange: Toronto
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Tekmira Pharmaceuticals Corp+ Add to Watchlist
TKM:CN16.4200 CAD 0.2200 1.36%
As of 13:00:00 ET on 12/24/2014.
Company Profile for Tekmira Pharmaceuticals Corp (TKM)
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.
Tekmira Pharmaceuticals Corp
Key Executives for Tekmira Pharmaceuticals Corp (TKM)
|Mark J MurrayPresident/CEO||Bruce CousinsExec VP:Finance/CFO|
|Ian MaclachlanExec VP/Chief Technical Officer||Michael J AbramsExec VP/Chief Discovery Officer|
|Mark KowalskiSenior VP/Chief Medical Officer||Peter LutwycheSenior VP:Pharmaceutical Dev|
|Julie P RezlerDirector:Investor Relations||Jodi RegtsDir:Investor Relations|
|R Hector Mackay-DunnSecretary|